Covestor LTD Agenus Inc Transaction History

Covestor LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.53 - $0.93 $882 - $1,549	-1,666 Reduced 17.62%	7,790 $5,000
Q4 2023 Feb 09, 2024	SELL	$0.63 - $1.14 $292 - $528	-464 Reduced 4.68%	9,456 $8,000
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $4,212 - $7,070	3,761 Added 61.07%	9,920 $11,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $482 - $750	368 Added 6.35%	6,159 $10,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $294 - $598	-203 Reduced 3.39%	5,791 $9,000
Q4 2022 Feb 13, 2023	SELL	$2.02 - $3.25 $953 - $1,534	-472 Reduced 7.3%	5,994 $14,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $7 - $12	-4 Reduced 0.06%	6,466 $13,000
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.64 $1,606 - $3,263	-1,236 Reduced 16.04%	6,470 $13,000
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $4,925 - $7,273	-2,096 Reduced 21.38%	7,706 $19,000
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $28,621 - $56,263	9,802 New	9,802 $32,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.